AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Cannabix Technologies Inc.

$0.3 -$0.14 (-31.32%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0.31
Day Range
$0.3$0.3
Year Range
$0.26$0.68
Market Cap
36.41M
AVG Volume
71.58K
Trailing/Forward PE
-8.54/-
PEG ratio
0.4
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (CAD)
0102030402017201820192020202120222023202420252026
BLOZF Revenue (CAD) by year
PeriodRevenue (CAD)
202636
20250
20240
20230
20220
20210
20200
20190
20180
20170
Net Income (CAD)
-10M-7.5M-5M-2.5M02017201820192020202120222023202420252026
BLOZF Net Income (CAD) by year
PeriodNet Income (CAD)
2026-5.76M
2025-4.69M
2024-3.13M
2023-2.14M
2022-3.37M
2021-9.24M
2020-6.97M
2019-3.88M
2018-1.47M
2017-3.73M
Operating Income (CAD)
-20M-15M-10M-5M02017201820192020202120222023202420252026
BLOZF Operating Income (CAD) by year
PeriodOperating Income (CAD)
2026-5.92M
2025-4.62M
2024-2.96M
2023-2.28M
2022-3.4M
2021-15.91M
2020-3.18M
2019-4.02M
2018-1.47M
2017-3.74M
EBITDA (CAD)
-20M-15M-10M-5M02017201820192020202120222023202420252026
BLOZF EBITDA (CAD) by year
PeriodEBITDA (CAD)
2026-5.59M
2025-4.5M
2024-2.86M
2023-1.95M
2022-3.37M
2021-15.88M
2020-3.16M
2019-4M
2018-1.47M
2017-3.74M
Cash Flows (CAD)
-3M-2M-1M02017201820192020202120222023202420252026
BLOZF Cash Flows (CAD) by year
PeriodCash Flows (CAD)
2026-1.74M
2025-1.86M
2024-2.1M
2023-2M
2022-2.13M
2021-1.79M
2020-1.89M
2019-1.88M
2018-1.5M
2017-1.2M
EPS (CAD)
-60-40-2002017201820192020202120222023202420252026
BLOZF EPS (CAD) by year
PeriodEPS (CAD)
2026-0.05
2025-0.04
2024-0.03
2023-0.02
2022-0.03
2021-4.73
2020-42.73
2019-7.8
2018-4.88
2017-13.92
Expenses (CAD)
02M4M6MR&DSG&ACapex2017201820192020202120222023202420252026
BLOZF Expenses (CAD) by year
PeriodExpenses (CAD)
20265.61M
20254.33M
20242.92M
20231.92M
20223.26M
20212.66M
20203.07M
20193.9M
20181.48M
20173.72M
Cash & Debt (CAD)
05M10M15M2017201820192020202120222023202420252026
BLOZF Cash & Debt (CAD) by year
PeriodCash & Debt (CAD)
20261.59M
20252.35M
20244.26M
20236.52M
20228.45M
202110.1M
20208.44M
201910.27M
201811M
20173.55M
Debt ratios
00.511.520192020202120222023202420252026
BLOZF Debt ratios by year
PeriodDebt ratios
20260.1
20250.17
20240.17
20230.26
20220.32
20210.41
20200.68
20191.01
Margins
-800000%-600000%-400000%-200000%0%2026
BLOZF Margins by year
PeriodMargins
2026-694602.78%
Return on Capital
-400%-300%-200%-100%0%2017201820192020202120222023202420252026
BLOZF Return on Capital by year
PeriodReturn on Capital
2026-323.55%
2025-183.69%
2024-70.24%
2023-31.87%
2022-38.98%
2021-89.74%
2020-80.63%
2019-27.05%
2018-9.84%
2017-50.18%
Shares Outstanding
050M100M150M2017201820192020202120222023202420252026
BLOZF Shares Outstanding by year
PeriodShares Outstanding
2026120.63M
2025114.89M
2024114.15M
2023114.17M
2022114.14M
2021112.19M
2020105.11M
2019103.44M
201898.09M
201787.14M
Book Value Per Share (CAD)
00.050.10.150.22017201820192020202120222023202420252026
BLOZF Book Value Per Share (CAD) by year
PeriodBook Value Per Share (CAD)
20260.01
20250.02
20240.04
20230.06
20220.08
20210.09
20200.08
20190.14
20180.15
20170.09
Total Assets (CAD)
05M10M15M20M2017201820192020202120222023202420252026
BLOZF Total Assets (CAD) by year
PeriodTotal Assets (CAD)
20262.21M
20253M
20244.7M
20236.95M
20228.76M
202110.38M
20208.74M
201914.56M
201815.1M
20177.6M
Free Cash Flow Yield
-6%-5%-4%-3%-2%med -2.94%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
BLOZF Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-3.5%
Sep 26-3.06%
Aug 26-2.93%
Aug 26-2.9%
Aug 26-2.82%
Aug 26-2.58%
Jul 26-2.84%
Jul 26-2.79%
Jul 26-2.81%
Jul 26-2.56%
Jul 26-2.81%
Jun 26-2.8%
Jun 26-2.54%
Jun 26-2.59%
Jun 26-2.44%
May 26-2.37%
May 26-2.39%
May 26-2.19%
May 26-2.16%
May 26-2.18%
Apr 26-2.25%
Apr 26-2.28%
Apr 26-2.2%
Apr 26-2.31%
Mar 26-2.18%
Mar 26-2.34%
Mar 26-3.31%
Mar 26-3.32%
Feb 26-3.02%
Feb 26-3.02%
Feb 26-3.13%
Feb 26-2.91%
Jan 26-2.85%
Jan 26-2.69%
Jan 26-2.61%
Jan 26-2.65%
Jan 26-2.78%
Dec 25-2.84%
Dec 25-2.91%
Dec 25-3.03%
Dec 25-3.24%
Nov 25-3.17%
Nov 25-2.98%
Nov 25-2.94%
Nov 25-2.91%
Oct 25-3.17%
Oct 25-3.02%
Oct 25-3.06%
Oct 25-2.97%
Oct 25-2.67%
Sep 25-2.99%
Sep 25-2.9%
Sep 25-2.89%
Sep 25-2.82%
Aug 25-2.8%
Aug 25-2.76%
Aug 25-2.8%
Aug 25-2.67%
Aug 25-2.78%
Jul 25-2.95%
Jul 25-2.85%
Jul 25-3.11%
Jul 25-2.84%
Jun 25-2.86%
Jun 25-2.85%
Jun 25-2.87%
Jun 25-2.8%
May 25-3.01%
May 25-3.03%
May 25-2.92%
May 25-3.12%
May 25-3.15%
Apr 25-3.14%
Apr 25-2.83%
Apr 25-2.95%
Apr 25-2.99%
Mar 25-3.43%
Mar 25-3.22%
Mar 25-3.27%
Mar 25-4.06%
Feb 25-4.11%
Feb 25-3.5%
Feb 25-3.7%
Feb 25-3.73%
Jan 25-3.16%
Jan 25-3.76%
Jan 25-4.69%
Jan 25-5.24%
Jan 25-5.57%
Dec 24-5.51%
Dec 24-5.56%
Dec 24-5.42%
Dec 24-4.72%
Nov 24-4.81%
Nov 24-5.02%
Nov 24-5.14%
Nov 24-4.26%
Nov 24-4.2%
Oct 24-4.07%
Oct 24-4.23%
Price to Sales
0500000100000015000002000000med 550.16Feb 26Mar 26Apr 26May 26Jul 26Aug 26Sep 26
BLOZF Price to Sales by year
PeriodPrice to Sales
Sep 261379484.29
Sep 261576914.82
Aug 261644261.7
Aug 261660196.85
Aug 261707778.63
Aug 261867796.68
Jul 261699574.56
Jul 26424.54
Jul 26421.87
Jul 26461.64
Jul 26421.48
Jun 26422.55
Jun 26466.59
Jun 26456.96
Jun 26485.19
May 26499.9
May 26495.95
May 26541.48
May 26548.19
May 26543.66
Apr 26739.69
Apr 26731.23
Apr 26758.01
Apr 26719.12
Mar 26763.42
Mar 26710.52
Mar 26502.99
Mar 26501.89
Feb 26550.16
Feb 26551.73
Feb 26532.31
Feb 26571.78
Jan 26582.91
Price to Book
0204060med 26.13Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
BLOZF Price to Book by year
PeriodPrice to Book
Sep 2627.88
Sep 2631.87
Aug 2633.23
Aug 2633.55
Aug 2634.51
Aug 2637.75
Jul 2634.35
Jul 2642.82
Jul 2642.55
Jul 2646.56
Jul 2642.51
Jun 2642.62
Jun 2647.06
Jun 2646.09
Jun 2648.94
May 2650.42
May 2650.02
May 2654.61
May 2655.29
May 2654.83
Apr 2648.69
Apr 2648.13
Apr 2649.89
Apr 2647.33
Mar 2650.25
Mar 2646.77
Mar 2633.11
Mar 2633.04
Feb 2636.21
Feb 2636.32
Feb 2635.04
Feb 2637.64
Jan 2638.37
Jan 2631.78
Jan 2632.79
Jan 2632.27
Jan 2630.8
Dec 2530.07
Dec 2529.42
Dec 2528.22
Dec 2526.37
Nov 2526.99
Nov 2528.7
Nov 2529.09
Nov 2529.37
Oct 2526.96
Oct 2524.1
Oct 2523.86
Oct 2524.58
Oct 2527.33
Sep 2524.42
Sep 2525.12
Sep 2525.24
Sep 2525.81
Aug 2526.05
Aug 2526.39
Aug 2526.01
Aug 2527.27
Aug 2526.21
Jul 2522.81
Jul 2523.62
Jul 2521.64
Jul 2523.65
Jun 2523.48
Jun 2523.58
Jun 2523.44
Jun 2524.02
May 2522.32
May 2522.16
May 2523.06
May 2521.56
May 2521.37
Apr 2518.79
Apr 2520.87
Apr 2520
Apr 2519.77
Mar 2517.2
Mar 2518.3
Mar 2518.07
Mar 2514.53
Feb 2514.35
Feb 2516.86
Feb 2515.95
Feb 2515.84
Jan 2518.69
Jan 2514.44
Jan 2511.58
Jan 2510.38
Jan 259.75
Dec 249.86
Dec 249.77
Dec 2410.02
Dec 2411.52
Nov 2411.29
Nov 2410.83
Nov 2410.58
Nov 2412.76
Nov 2412.93
Oct 2411.57
Oct 2411.15
Cannabix Technologies Inc.
BLOZF
Stockpicker

Video analysis: BLOZF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BLOZF

Cannabix Technologies Deploys BreathLogix Alcohol Monitoring System with Lake County Community Corrections in Indiana's Second-Most Populous County

globenewswire.com · 10 Sep 2026

Cannabix Technologies Deploys BreathLogix Alcohol Monitoring System with Lake County Community Corrections in Indiana's Second-Most Populous County

VANCOUVER, British Columbia, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (the “Company or Cannabix”) developer of marijuana and alcohol breath testing technologies, is pleased to announce the deployment of its BreathLogix alcohol monitoring solution with the Lake County Community Corrections Program in Indiana. Lake County is Indiana's second-most populous county, serving residents in the greater Chicago metropolitan region.

Cannabix Technologies Deploys BreathLogix Alcohol System at Montana's Big Horn County Probation and Pre-Trial Services Department Under State's 24/7 Sobriety Program

globenewswire.com · 20 Aug 2026

Cannabix Technologies Deploys BreathLogix Alcohol System at Montana's Big Horn County Probation and Pre-Trial Services Department Under State's 24/7 Sobriety Program

VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices, is pleased to announce the deployment of its BreathLogix alcohol screening solution with the Big Horn County Misdemeanor Probation and Pre-trial Services in Montana. The BreathLogix system will be located at the county detention center and overseen by the misdemeanor probation and pre-trial staff. The technology will support participant monitoring under Montana's 24/7 Sobriety Program and assist courts with compliance monitoring both within and beyond county jurisdictions. The deployment is being facilitated by AlcoPro, Inc., an authorized reseller.

Cannabix Targets Combat Sports Market for Commercial Rollout of Marijuana Breath Test at ABC Boxing & MMA Conference

globenewswire.com · 4 Aug 2026

Cannabix Targets Combat Sports Market for Commercial Rollout of Marijuana Breath Test at ABC Boxing & MMA Conference

VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”), a developer of marijuana and alcohol breath testing technologies for workplace and public safety is pleased to announce that its Marijuana Breath Test ("MBT") technology has been invited for presentation at the Association of Boxing Commissions and Combative Sports ("ABC") 38th Annual Conference, to be held at the Caribe Royale Resort in Orlando, Florida in August. The conference is recognized as one of the leading gatherings of combat sports regulators, athletic commissioners, medical professionals, referees, judges, inspectors, and industry stakeholders involved in professional boxing, mixed martial arts (MMA) and other combative sports.

Cannabix Technologies Annual General Meeting Results

globenewswire.com · 31 Jul 2026

Cannabix Technologies Annual General Meeting Results

VANCOUVER, British Columbia, July 31, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) announces the results of its annual general meeting of common shareholders held on July 27, 2026 in Vancouver. Resolutions passed at the meeting included the appointment of SHIM and Associates LLP as auditors for the ensuing year, and the election of five directors: Dr. Raj Attariwala, Dr. Phillip Olla, Ravinder Mlait, Bryan Loree, and William Corl.

Cannabix Technologies and Omega Laboratories Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection

globenewswire.com · 8 Jul 2026

Cannabix Technologies and Omega Laboratories Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection

Expanded breath-testing capability enables recent-use detection across a panel modeled after the DOT federally mandated urine drug test panel. Expanded breath-testing capability enables recent-use detection across a panel modeled after the DOT federally mandated urine drug test panel.

Omega Laboratories and Cannabix Technologies Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection

prnewswire.com · 8 Jul 2026

Omega Laboratories and Cannabix Technologies Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection

Expanded breath-testing capability enables recent-use detection across a panel modeled after the DOT federally mandated urine drug test panel. MOGADORE, Ohio and VANCOUVER, BC, July 8, 2026 /PRNewswire/ -- Omega Laboratories, Inc. ("Omega"), and Cannabix Technologies Inc. ("Cannabix") (CSE: BLO) (OTCID: BLOZF) announce the development and validation of a DOT-like drug-test panel for breath testing.

Cannabix Technologies Announces Detection of Methamphetamine and Amphetamine in Human Breath

globenewswire.com · 2 Jul 2026

Cannabix Technologies Announces Detection of Methamphetamine and Amphetamine in Human Breath

Methamphetamine & Amphetamine Detection in Breath Represents a Significant New Opportunity for Cannabix Technologies Inc. Methamphetamine & Amphetamine Detection in Breath Represents a Significant New Opportunity for Cannabix Technologies Inc.

Cannabix Technologies Announces First BreathLogix Alcohol Device Deployment to West Africa for Mining Sector

globenewswire.com · 29 Jun 2026

Cannabix Technologies Announces First BreathLogix Alcohol Device Deployment to West Africa for Mining Sector

VANCOUVER, British Columbia, June 29, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices, is pleased to announce its first deployment of BreathLogix alcohol screening devices in Africa, through a West African distributor specializing in industrial safety solutions for mining clients. The delivery is being coordinated through Montreal based Alco Prevention Canada.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.